γ-synuclein has a dynamic intracellular localization

Cell Motility and the Cytoskeleton

Volumn 63, Issue 8, 2006, Pages 447-458

  Surgucheva, Irina ^a,b   McMahon, Belinda ^a,b   Surguchov, Andrei ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Actin; Astrocytes; Centrosomes; Midbody; Nucleus

Indexed keywords

BETA SYNUCLEIN; GAMMA SYNUCLEIN;

ANIMAL CELL; ARTICLE; CANCER; CELL NUCLEUS; CENTROSOME; EYE DISEASE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MITOSIS; MOUSE; MUTATION; NERVE CELL CULTURE; NERVE FIBER GROWTH; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STRESS; TELOPHASE;

ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; CENTROSOME; CYTOPLASM; GAMMA-SYNUCLEIN; HUMANS; MICE; NEURITES; NEURONS; PROTEIN TRANSPORT;

EID: 33746662899     PISSN: 08861544     EISSN: 10970169     Source Type: Journal    
DOI: 10.1002/cm.20135     Document Type: Article

References (64)

1. Alim MA, Hossain MS, Arima K, Takeda K, Izumiyama Y, Nakamura M, Kaji H, Shinoda T, Hisanaga S, Ueda K. 2002. Tubulin seeds α-synuclein fibril formation. J Biol Chem 277(3):2112-2117.
2. Al-Ubaidi MR, Font RL, Quiambao AB, Keener MJ, Liou GI, Overbeek PA, Baehr W. 1992. Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. J Cell Biol 119:1681-1687.
3. Bellissent-Waydelich A, Vanier MT, Albiges-Rizo C, Simon-Assmann P. 1999. Talin concentrates to the midbody region during mammalian cell cytokinesis. J Histochem Cytochem 47(11):1357-1368.
4. Bennett MC. 2005. The role of α-synuclein in neurodegenerative diseases. Pharmacol Ther 105(3):311-331.
5. Brenz Verca MS, Bahi A, Boyer F, Wagner GC, Dreyer JL. 2003. Distribution of α- and γ-synucleins in the adult rat brain and their modification by high-dose cocaine treatment. Eur J Neurosci 18(7):1923-1938.
6. Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, Godwin AK. 2000. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88(9):2154-2163.
7. Buchman VL, Hunter HJ, Pinon LG, Thompson J, Privalova EM, Ninkina NN, Davies AM. 1998a. Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. J Neurosci 18(22):9335-9341.
8. Buchman VL, Adu J, Pinon LGP, Ninkina NN, Davies AM. 1998b. Persyn, a member of the synuclein family, influences neurofilament network integrity. Nat Neurosci 1:101-103.
9. Clayton DF, George JM. 1999. Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res 58(1):120-129.
10. Crowther RA, Jakes R, Spillantini MG, Goedert M. 1998. Synthetic filaments assembled from C-terminally truncated α-synuclein. FEBS Lett 436(3):309-312.
11. da Costa CA, Masliah E, Checler F. 2003. β-Synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: Crosstalk with α-synuclein and implication for Parkinson's disease. J Biol Chem 278(39):37330-37335.
12. El-Agnaf OM, Jakes R, Curran MD, Wallace A. 1998. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease. FEBS Lett 440(1/2):67-70.
13. Ellison G, Klinowska T, Westwood RFR, Docter E, French T, Fox JC. 2002. Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol 55(5):294-299.
14. Espinoza LA, Valikhani M, Cossio MJ, Carr T, Jung M, Hyde J, Witten ML, Smulson ME. 2005. Altered expression of γ-synuclein and detoxification-related genes in lungs of rats exposed to JP-8. Am J Respir Cell Mol Biol 32:192-200.
15. Fung KM, Rorke LB, Giasson B, Lee VM, Trojanowski JQ. 2003. Expression of α-, β-, and γ-synuclein in glial tumors and medulloblastomas. Acta Neuropathol (Berl) 106(2):167-175.
16. Galvin JE, Uryu K, Lee VM, Trojanowski JQ. 1999. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains α-, β-, and γ-synuclein. Proc Natl Acad Sci USA 96(23):13450-13455.
17. Galvin JE, Giasson B, Hurtig HI, Lee VM, Trojanowski JQ. 2000. Neurodegeneration with brain iron accumulation, type 1 is characterized by α-, β-, and γ-synuclein neuropathology. Am J Pathol 157(2):361-368.
18. Giasson BI, Uryu K, Trojanowski JQ, Lee VM. 1999. Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 274(12):7619-7622.
19. Gillingham AK, Munro S. 2000. The PACT domain, a conserved centrosomal targeting motif in the coiled-coil proteins AKAP450 and pericentrin. EMBO Rep 1(6):524-529.
20. Goedert M. 1999. Filamentous nerve cell inclusions in neurodegenerative diseases: Tauopathies and α-synucleinopathies. Philos Trans R Soc Lond B Biol Sci 354(1386):1101-1118.
21. Goers J, Manning-Bog AB, McCormack AL, Millett IS, Doniach S, Di Monte DA, Uversky VN, Fink AL. 2003. Nuclear localization of α-synuclein and its interaction with histones. Biochemistry 42(28):8465-8471.
22. Gupta A, Inaba S, Wong OK, Fang G, Liu J. 2003. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene 22(48):7593-7599.
23. Hashimoto M, Yoshimoto M, Sisk A, Hsu LJ, Sundsmo M, Kittel A, Saitoh T, Miller A, Masliah E. 1997. NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation. Biochem Biophys Res Commun 237(3):611-616.
24. Hashimoto M, Takenouchi T, Rockenstein E, Masliah E. 2003. α-Synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: Role in the pathogenesis of Parkinson's disease. J Neurochem 85(6):1468-1479.
25. Inaba S, Li C, Shi YE, Song DQ, Jiang JD, Liu J. 2005. Synuclein γ inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat 94(1):25-35.
26. Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, Terai A, Arai Y, Iwamura H, Kawakita M, Yoshiki T. 2004. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, γ-synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Canc Sci 95(12):955-961.
27. Jakes R, Spillantini MG, Goedert M. 1994. Identification of two distinct synucleins from human brain. FEBS Lett 345:27-32.
28. Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C, Shi Y. 1997. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Canc Res 57:759-764.
29. Jia T, Liu YE, Liu J, Shi YE. 1999. Stimulation of breast cancer invasion and metastasis by synuclein γ. Cane Res 59:742-747.
30. Krishnamoorthy RR, Crawford MJ, Chaturvedi MM, Jain SK, Aggarwal BB, Al-Ubaidi MR, Agarwal N. 1999. Photo-oxidative stress down-modulates the activity of nuclear factor-κB via involvement of caspase-1, leading to apoptosis of photoreceptor cells. J Biol Chem 274(6):3734-3743.
31. Krüeger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O. 1998. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 18:106-108.
32. Lavedan C, Leroy E, Dehejia A, Buchholtz S, Dutra A, Nussbaum RL, Polymeropoulos MH. 1998. Identification, localization and characterization of the human α-synuclein gene. Hum Genet 103:106-112.
33. Li Z, Sclabas GM, Peng B, Hess KR, Abbruzzese JL, Evans DB, Chiao PJ. 2004. Overexpression of synuclein-γ in pancreatic adenocarcinoma. Cancer 101(s1):58-65.
34. Maroteaux L, Campanelli JT, Scheller RH. 1988. Synuclein: A neuron specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804-2815.
35. Maurage CA, Ruchoux MM, de Vos R, Surguchov A, Destee A. 2003. Retinal involvement in dementia with Lewy bodies: A clue to hallucinations? Ann Neurol 54(4):542-547.
36. McLean PJ, Kawamata H, Ribich S, Hyman BT. 2000. Membrane association and protein conformation of α-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. J Biol Chem 275(12):8812-8816.
37. Ninkina NN, Alimova-Kost MV, Paterson JWE, Delaney L, Cohen BB, Imreh S, Gnuchev NV, Davies AM, Buchman VL. 1998a. Organization, expression and polymorphism of the human persyn gene. Hum Mol Genet 7:1417-1424.
38. Ninkina N, Privalova E, Pinon L, Davies AM, Buchman VL. 1998b. Developmentally regulated expression of persyn, a member of the synuclein family, in skin. Exp Cell Res 246:308-311.
39. Norris EH, Giasson BI, Lee VM. 2004. α-synuclein: Normal function and role in neurodegenerative diseases. Curr Top Dev Biol 60:17-54.
40. Pinhasov A, Ilyin SE, Crooke J, Amato FA, Vaidya AH, Rosenthal D, Brenneman DE, Malatynska E. 2005. Different levels of γ-synuclein mRNA in the cerebral cortex of dominant, neutral and submissive rats selected in the competition test. Gene Brain Behav 4(1):60-64.
41. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos E, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, DiIorio G, Golbe LI, Nussbaum RL. 1997. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047.
42. Pronin A, Morris A, Surguchov A, Benovic JL. 2000. Synucleins are a novel class of substrates for G protein-coupled receptor kinase. J Biol Chem 275(34):26515-26522.
43. Reid TW, Albert DM, Rabson AS, Russell P, Craft J, Chu EW, Tralka TS, Wilcox JL. 1974. Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst 53:347-360.
44. Rhee HJ, Kim GY, Huh JW, Kim SW, Na DS. 2000. Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur J Biochem 267:3220-3225.
45. Rodriguez P, Pelletier J, Price GB, Zannis-Hadjopoulos M. 2000. NAP-2: Histone chaperone function and phosphorylation state through the cell cycle. J Mol Biol 298:225-238.
46. Roque RS, Rosales AA, Jingjing L, Agarwal N, Al-Ubaidi MR. 1999. Retina-derived microglial cells induce photoreceptor cell death in vitro. Brain Res 836(1/2):110-119.
47. Scholey JM, Brust-Mascher I, Mogilner A. 2003. A Cell division. Nature 422:746-752.
48. Shults CW. 2006. Lewy bodies. Proc Natl Acad Sci USA 103:1661-1668.
49. Snyder H, Mensah K, Hsu C, Hashimoto M, Surgucheva IG, Festoff B, Surguchov A, Masliah E, Matouschek A, Wolozin B. 2005. β-Synuclein reduces proteasomal inhibition by α-synuclein but not γ-synuclein. J Biol Chem 280(9):7562-7569.
50. Souza JM, Giasson BI, Chen Q, Lee VM, Ischiropoulos H. 2000a. Dityrosine cross-linking promotes formation of stable a-synuclein polymers: Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem 275(24):18344-18349.
51. Souza JM, Giasson BI, Lee VM, Ischiropoulosa H. 2000b. Chaperone-like activity of synucleins. FEBS Lett 474(1):116-119.
52. Spillantini MG, Schmidt ML, Le VMY, Trojanowski JQ, Jakes R, Goedert M. 1997. α-Synuclein in Lewy bodies. Nature 388:839-840.
53. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. 1998. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95(11):6469-6473.
54. Surgucheva I, McMahan B, Ahmed F, Tomarev S, Wax MB, Surguchov A. 2002. Synucleins in glaucoma: Implication of γ-synuclein in glaucomatous alterations in the optic nerve. J Neurosci Res 68:97-106.
55. Surgucheva I, Yue BY, Park BC, Tomarev S, Surguchov A. 2005a. Interaction of myocilin with γ-synuclein and its role in neurodegeneration in glaucoma. Cell Mol Neurobiol 25(6):1009-1033.
56. Surgucheva I, Ninkina N, Buchman VL, Grasing K, Surguchov A. 2005b. Protein aggregation in retinal cells and approaches to cell protection. Cell Mol Neurobiol 25(6):1051-1066.
57. Surgucheva IG, Sivak JM, Fini ME, Palazzo RE, Surguchov AP. 2003. Effect of γ-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells. Arch Biochem Biophys 410:167-176.
58. Surguchov A, Surgucheva I, Solessio E, Baehr W. 1999. Synoretin-A new protein belonging to the synuclein family. Mol Cell Neurosci 13:95-103.
59. Surguchov A, McMahon B, Masliah E, Surgucheva I. 2001a. Synucleins in ocular tissues. J Neurosci Res 65:68-77.
60. Surguchov A, Palazzo RE, Surgucheva I. 2001b. γ Synucleins: Subcellular localization in neuronal and non-neuronal cells and effect on signal transduction. Cell Motil Cytoskeleton 49:218-228.
61. Takenouchi T, Hashimoto M, Hsu LJ, Mackowski B, Rockenstein E, Mallory M, Masliah E. 2001. Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human α-synuclein. Mol Cell Neurosci 17(1):141-150.
62. Trojanowski JQ, Goedert M, Iwatsubo T, Lee VM. 1998. Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Differ 5(10):832-837.
63. Wang YL, Takeda A, Osaka H, Hara Y, Furuta A, Setsuie R, Sun YJ, Kwon J, Sato Y, Sakurai M, Noda M, Yoshikawa Y, Wada K. 2004. Accumulation of β- and γ-synucleins in the ubiquitin carboxyl-terminal hydrolase L1-deficient gad mouse. Brain Res 1019(1-/2):1-9
64. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG. 2004. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164-173.